Screener
Microbot Medical MBOT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Microbot Medical’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001493152-26-037009
FAQ
- What is Microbot Medical's EPS (diluted)?
- Microbot Medical (MBOT) reported EPS (diluted) of -$0.08 in Q2 2026.
- How has Microbot Medical's EPS (diluted) changed year-over-year?
- Microbot Medical's EPS (diluted) increased by 20.0% year-over-year, from -$0.10 to -$0.08.
- What is the long-term trend for Microbot Medical's EPS (diluted)?
- Over 4 years (2021 to 2025), Microbot Medical's EPS (diluted) has grown at a -34.6% compound annual growth rate (CAGR), from -$1.59 to -$0.29.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Microbot Medical's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude